Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve (a) The Audited Financial Results for the fourth quarter and year ended March 31, 2026, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; (b) The audited Balance Sheet as at March 31, 2026, and Statement of Profit and Loss for the year ended March 31, 2026 and; (c) Other corporate matters.